PubMed · 2031339
Alloantiserum recognizing a DQw2 split which is associated with DR3.
Abstract
A typing serum MUE 38539 II, was found to recognize a DR3-associated split of DQw2. In cytotoxicity tests, MUE 38539 II yielded positive test results with B lymphocytes but not with monocytes of DR3-positive cell donors. This was in contrast to other typing reagents for DR3 that react with B lymphocytes as well as monocytes. Lymphocytotoxicity tests using MUE 38539 II were negative with DR7- and DQw2-positive cells. The assumption that the serum recognizes a DR3-associated split of DQw2, and not DR3 itself, was confirmed by the lack of reactivity with a DQw4- and DR3-positive lymphoblastoid cell line (RSH). The assumption was also corroborated using reagents from a family in which DR3 and DQw2 were not found in the usually described linkage. In two lines, DR3 was associated with DQw- (2707 and 2710), and in the cell line 2704, DQw2 was associated with DRw-. The serum MUE 38539 II was exclusively cytotoxic with lymphoblastoid cell lines from those family members who were positive for DQw2, independently of the DR3 antigens of the cells.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
B Flesch, J Neppert, P Ziegler, G Achtert. 1991. Alloantiserum recognizing a DQw2 split which is associated with DR3.. https://doi.org/10.1111/j.1423-0410.1991.tb00885.x
Cite the original work for its findings. Save a collection to share your selection of sources.